Position in VTRS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$808,247
+$205,108 QoQ
Shares Held
59,826
+23.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 86.82178317119647.ToString("F0")%
Shared 0.ToString("F0")%
None 13.17821682880353.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Rockefeller Capital Management L.P. holds $133,569,034 across 49 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
5,103,509 | $51,086,123 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
282,097 | $37,163,457 | |
| 3 | ZTS |
Zoetis Inc.
|
253,206 | $29,931,479 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
173,438 | $8,351,039 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
64,920 | $1,553,534 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
1,562 | $926,232 | |
| 7 | VTRS |
Viatris Inc
This page
|
59,826 | $808,247 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
47,612 | $659,425 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $808,247 | 59,826 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $603,139 | 48,445 | Shares | Defined | 2026-03-17 | |
| 2025-09-30 | $451,241 | 45,580 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $375,291 | 42,026 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $242,581 | 27,851 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $368,071 | 29,564 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $383,627 | 33,043 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $316,496 | 29,774 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $393,577 | 32,963 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $428,325 | 39,550 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $375,703 | 38,104 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $225,916 | 22,637 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $272,398 | 28,316 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $327,576 | 29,432 | Shares | Defined | 2023-03-06 | |
| 2022-09-30 | $285,614 | 33,523 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $341,519 | 32,619 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $380,918 | 35,011 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $453,660 | 33,530 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $534,274 | 39,430 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $698,564 | 48,885 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $650,204 | 46,543 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $1,961,945 | 104,693 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||